Javascript must be enabled to continue!
Neuronal Activity-Induced BRG1 Phosphorylation Regulates Enhancer Activation
View through CrossRef
SUMMARY
Neuronal activity-induced enhancers drive the gene induction in response to stimulation. Here, we demonstrate that BRG1, the core subunit of SWI/SNF-like BAF ATP-dependent chromatin remodeling complexes, regulates neuronal activity-induced enhancers. Upon stimulation, BRG1 is recruited to enhancers in an H3K27Ac-dependent manner. BRG1 regulates enhancer basal activities and inducibility by affecting cohesin binding, enhancer-promoter looping, RNA polymerase II recruitment, and enhancer RNA expression. Furthermore, we identified a serine phosphorylation site in BRG1 that is induced by neuronal activities and is sensitive to CaMKII inhibition. BRG1 phosphorylation affects its interaction with several transcription co-factors, possibly modulating BRG1 mediated transcription outcomes. Using mice with knock-in mutations, we showed that non-phosphorylatable BRG1 fails to efficiently induce activity-dependent genes, whereas phosphomimic BRG1 increases the enhancer activities and inducibility. These mutant mice displayed anxiety-like phenotypes and altered responses to stress. Therefore, our data reveal a mechanism connecting neuronal signaling to enhancer activities through BRG1 phosphorylation.
Title: Neuronal Activity-Induced BRG1 Phosphorylation Regulates Enhancer Activation
Description:
SUMMARY
Neuronal activity-induced enhancers drive the gene induction in response to stimulation.
Here, we demonstrate that BRG1, the core subunit of SWI/SNF-like BAF ATP-dependent chromatin remodeling complexes, regulates neuronal activity-induced enhancers.
Upon stimulation, BRG1 is recruited to enhancers in an H3K27Ac-dependent manner.
BRG1 regulates enhancer basal activities and inducibility by affecting cohesin binding, enhancer-promoter looping, RNA polymerase II recruitment, and enhancer RNA expression.
Furthermore, we identified a serine phosphorylation site in BRG1 that is induced by neuronal activities and is sensitive to CaMKII inhibition.
BRG1 phosphorylation affects its interaction with several transcription co-factors, possibly modulating BRG1 mediated transcription outcomes.
Using mice with knock-in mutations, we showed that non-phosphorylatable BRG1 fails to efficiently induce activity-dependent genes, whereas phosphomimic BRG1 increases the enhancer activities and inducibility.
These mutant mice displayed anxiety-like phenotypes and altered responses to stress.
Therefore, our data reveal a mechanism connecting neuronal signaling to enhancer activities through BRG1 phosphorylation.
Related Results
Abstract 1651: Targeting intermediates of the PRMT5/BRG1 axis as a combination therapy
Abstract 1651: Targeting intermediates of the PRMT5/BRG1 axis as a combination therapy
Abstract
Over 40% of colorectal cancer (CRC) patients harbor a mutation in the KRAS gene, leading to a worse prognosis. PRMT5 and BRG1 are proteins considered potent...
Abstract 2995: CDK9 phosphorylates BRG1 chromatin remodeler
Abstract 2995: CDK9 phosphorylates BRG1 chromatin remodeler
Abstract
Cyclin-dependent kinase 9 (CDK9) belongs to the class of CDKs involved in transcription regulation along with CDK7, 8, 10-13. Earlier works have established...
Abstract 1769: A selective BRM (SMARCA2) inhibitor for the treatment of BRG1 (SMARCA4) mutant cancers
Abstract 1769: A selective BRM (SMARCA2) inhibitor for the treatment of BRG1 (SMARCA4) mutant cancers
Abstract
Background:
ATP-dependent BRG1/BRM associated factor complexes play a key role in regulating gene expression by remodel...
Regulation of ATM and ATR by Smarcal1 and BRG1
Regulation of ATM and ATR by Smarcal1 and BRG1
ABSTRACTThe G2/M checkpoint is activated on DNA damage by the ATM and ATR kinases that are regulated by post-translational modifications. In this paper, the transcriptional co-regu...
Abstract 602: Silencing BRG1 in human cancers
Abstract 602: Silencing BRG1 in human cancers
Abstract
BRG1 is a novel tumor suppressor that serves as the major catalytic subunit of the SWI/SNF complex. Because this complex is central to the function of a num...
A reversible KO model reveals therapeutic potentials of defective Tregs
A reversible KO model reveals therapeutic potentials of defective Tregs
ABSTRACT
Tregs must be activated to suppress immune responses, but the transcriptional program controlling Treg activation remains incompletely u...
Enhancer-based gene therapy: a new path for precision medicine
Enhancer-based gene therapy: a new path for precision medicine
Summary
Enhancers are critical cis-regulatory elements that regulate gene expression in a context-dependent manner by integrating transcription factor binding, ch...
The Bromodomains of the mammalian SWI/SNF (mSWI/SNF) ATPases Brahma (BRM) and Brahma Related Gene 1 (BRG1) promote chromatin interaction and are critical for skeletal muscle differentiation
The Bromodomains of the mammalian SWI/SNF (mSWI/SNF) ATPases Brahma (BRM) and Brahma Related Gene 1 (BRG1) promote chromatin interaction and are critical for skeletal muscle differentiation
ABSTRACT
Skeletal muscle differentiation induces changes in the epigenome of myoblasts as they proceed towards a myogenic phenotype. mSWI/SNF chromatin remodeling e...

